LONDONUS drug maker AbbVie Inc is close to clinching a deal to buy Dublinbased Shire PLC for more than  billion  billion in what would be one of the largest socalled inversion deals through which US companies are seeking a lower corporate tax burden After four days of renewed talks between the two drug makers Shire said Monday it had received a revised offer from AbbVie of  a share over the weekend Shire said it would be willing to recommend the deal to its shareholders subject to satisfactory
  